Globocan 2000 : cancer incidence, mortality and prevalence worldwide
By J. Ferlay, P. Pisani, D. M. Parkin. 2001
3,267 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/922fc4eae24531bd553909cc3e619232bef6d1d1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Mitchell Dowsett
- J. Llovet
- Jorge A. Marrero
- M. Hammond
- M. Hammond
- D. Parkin
- Antonio C. Wolff
- S. Badve
Citations in the corpus
- Alpha-fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound Alpha-fetoprotein in Early Hepatocellular Carcinoma (2009, background): “INTRODUCTION Hepatocellular carcinoma (HCC) is the fifth most common tumor and the third most common cause of cancer-related deaths worldwide (1,2).”
- The present and future burden of urinary bladder cancer in the world (2009, background): “Worldwide approximately 145,000 patients die from UBC annually [2].”
- Antibiotic use in relation to the risk of breast cancer (2004, unknown): “It is also the most common cancer in women worldwide, with more than 1 million cases diagnosed each year.(10) Antibiotics are used extensively and overused in many countries, though efforts are under way to curb overuse.”
- Recent advances in diffuse optical imaging (2005, background): “In 2000, more than 1 million women were diagnosed with breast cancer worldwide (Ferlay et al 2001).”
- American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). (2010, background): “In fact, breast cancer is the most common cancer among women worldwide, and many lower and lowermiddle income countries in Africa and Asia have mortality/incidence ratios that exceed those of countries in North America, Europe, or Australia.(42) Although these mortality/incidence ratios suggest that”